先天性心脏病婴儿住院期间发育风险筛查的早期识别
本研究回顾性观察325例3-12月龄先心病术后婴儿,出院前用Bayley-III筛查量表评估发育风险,各领域低于年龄预期的比例显著高于常模(各P<.001)。随访74例(23%)至12-42月龄,初始筛查高风险者后续Bayley-III表现更差(各领域P<.01),提示住院筛查有助于早期识别和转介。
要点
- 先心病术后婴儿出院前Bayley-III筛查各领域低于预期比例高,粗大运动79%。
- 初始筛查高风险者随访Bayley-III表现更差,各领域P<.01。
- 住院筛查可提供发育服务建议,可能克服门诊随访障碍。
核心结论
- 住院期间标准化神经发育筛查有助于识别先心病婴儿的发育风险,并为发育服务提供建议。
研究设计与样本
- 回顾性观察研究,便利样本为3-12月龄先心病术后婴儿,出院前接受Bayley-III筛查量表评估。
- 随访包括12-42月龄门诊Bayley-III评估。
主要发现
- 325例婴儿在中位5月8天(IQR 3月28天至7月17天)接受Bayley-III筛查。
- 各领域低于年龄预期比例:粗大运动79%、精细运动63%、接受性沟通50%、表达性沟通38%、认知38%,均高于常模(各P<.001)。
- 遗传综合征和较长住院时间与各领域更高风险类别几率增加相关。
- 74例(23%)在中位19月9天(IQR 17月3天至23月37天)完成门诊Bayley-III,初始筛查高风险者随访表现更差(各领域P<.01)。
临床怎么用
- 可考虑对先心病术后婴儿在出院前使用Bayley-III筛查量表进行发育风险筛查。
- 筛查高风险婴儿应提供发育服务建议,并关注遗传综合征和较长住院时间者。
局限性
- 回顾性观察研究,便利样本,随访率仅23%,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the utility of an inpatient standardized developmental screener for early identification of developmental risk in infants with a congenital heart defect (CHD). STUDY DESIGN: This was a retrospective, observational study with convenience sample of postoperative infants with CHD (aged 3-12 months) who underwent neurodevelopmental screening with the Bayley Scales of Infant and Toddler Development Screening Test, Third Edition (Bayley-III Screener) just before discharge. Follow-up testing included outpatient Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) (12-42 mo). RESULTS: The Bayley-III Screener was administered to 325 infants at a median of 5 months, 8 days (IQR 3 months, 28 days, to 7 months, 17 days). Infants scored below age expectations on the Gross Motor (79%), Fine Motor (63%), Receptive Communication (50%), Expressive Communication (38%), and Cognitive (38%) domains. In each domain, children with CHD had greater rates of scores below expectations than the normative sample (each P <.001). The odds of scoring in a greater risk category were increased for infants with genetic syndromes and longer length of hospital stay across all domains. The outpatient Bayley-III (n = 74, 23% follow-up) was completed at a median of 19 months, 9 days (IQR: 17 months, 3 days, to 23 months, 37 days). Individuals falling in greater-risk categories on their initial Bayley-III Screener were significantly more likely to have worse performance on their follow-up outpatient Bayley-III (each domain P < .01). CONCLUSIONS: Inpatient standardized neurodevelopmental screening provides important clinical utility in identifying infants at risk for developmental concern, allows for provision of recommendations for developmental services, and potentially overcomes barriers often noted in returning for outpatient post-discharge assessments.
引用
- Butler SC, Rofeberg V, Wypij D, et al. Inpatient Screening for Early Identification of Developmental Risk in Infants with Congenital Heart Defects. J Pediatr. 2023. PMID: 37611735. doi:10.1016/j.jpeds.2023.113687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。